A medicinal agent which is composed of 6-13 types of peptides derived from tumor antigens and can be used for the treatment of cancer, and which is characterized by being used in such a manner that antibodies against the peptides in peripheral blood collected from a patient are measured and a peptide against which an antibody is positive is selected and administered to the patient; and a peptide selection method.
